Journey Medical Corp (DERM) Net Income (Loss) Attributable to Parent USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Journey Medical Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2024.
  • Journey Medical Corp Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$10.4 M, a 3.02% decline year-over-year.
  • Journey Medical Corp Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$4.16 M, a 89.2% increase year-over-year.
  • Journey Medical Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$3.85 M, a 87% increase from 2022.
  • Journey Medical Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$29.6 M, a 32.7% increase from 2021.
  • Journey Medical Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$44 M, a 933% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$4.16 M -$10.4 M -$306 K -3.02% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$3.85 M -$2.14 M +$8.5 M +79.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$12.4 M $16.8 M +$26.9 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$39.2 M -$8.36 M -$835 K -11.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$38.4 M -$10.1 M -$8.76 M -636% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$29.6 M -$10.6 M +$11.1 M +51.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$40.7 M -$10.1 M +$566 K +5.32% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$41.3 M -$7.53 M +$4.34 M +36.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$45.6 M -$1.38 M -$1.65 M -614% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$44 M -$21.8 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$10.6 M -$10.7 M -36810% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$11.9 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $268 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $29 K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.